Linda Rhodes
2013
In 2013, Linda Rhodes earned a total compensation of $358.5K as Chief Scientific Officer at Aratana Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,500 |
|---|---|
| Option Awards | $55,304 |
| Salary | $225,000 |
| Other | $10,680 |
| Total | $358,484 |
Rhodes received $225K in salary, accounting for 63% of the total pay in 2013.
Rhodes also received $67.5K in non-equity incentive plan, $55.3K in option awards and $10.7K in other compensation.
Rankings
In 2013, Linda Rhodes' compensation ranked 10,363rd out of 12,286 executives tracked by ExecPay. In other words, Rhodes earned more than 15.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,363 out of 12,286 | 16th |
Division Manufacturing | 3,858 out of 4,612 | 16th |
Major group Chemicals And Allied Products | 1,229 out of 1,466 | 16th |
Industry group Drugs | 968 out of 1,160 | 17th |
Industry Pharmaceutical Preparations | 751 out of 890 | 16th |
Source: SEC filing on April 28, 2015.
Rhodes' colleagues
We found four more compensation records of executives who worked with Linda Rhodes at Aratana Therapeutics in 2013.